Kiora Pharmaceuticals shares surge 31.25% intraday on technical breakout and short squeeze.

Kiora Pharmaceuticals rose 31.25% during intraday trading, driven by a sharp technical breakout and short-covering activity rather than specific corporate announcements. The stock breached critical resistance levels near its 52-week high, triggering a rapid rally as momentum traders and short sellers rushed to cover positions. This move occurred in isolation from the broader pharmaceutical sector, which remained largely flat, indicating the surge was fueled by technical factors and high turnover volume rather than fundamental news events.